Yasufumi Kawanaka

Title: Yasufumi Kawanaka: Innovator in Pharmaceutical Crystallization

Introduction

Yasufumi Kawanaka is a notable inventor based in Sakai, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative crystal forms that enhance drug efficacy and safety. With a total of 3 patents to his name, Kawanaka's work is paving the way for advancements in medicinal chemistry.

Latest Patents

Kawanaka's latest patents focus on crystals comprising (2R)-2-propyloctanoic acid and an amine. These crystals are designed to be used as bulk drugs for safely orally administrable solid preparations while maintaining their pharmacological effects. Among these innovations, the crystal with dibenzylamine is particularly noteworthy, as it serves as a bulk drug for pharmaceuticals and can be utilized as an intermediate to produce (2R)-2-propyloctanoic acid with an optical purity exceeding 99.5% e.e., a feat that has not been achieved previously.

Career Highlights

Kawanaka is currently associated with Ono Pharmaceutical Co., Ltd., where he continues to push the boundaries of pharmaceutical research. His work is characterized by a commitment to improving drug formulations and ensuring their safety for patients.

Collaborations

Kawanaka collaborates with esteemed colleagues such as Tomoyuki Hasegawa and Eiji Kasamatsu. Their combined expertise contributes to the innovative research and development efforts at Ono Pharmaceutical Co., Ltd.

Conclusion

Yasufumi Kawanaka's contributions to pharmaceutical crystallization are significant and impactful. His innovative patents are set to enhance the safety and efficacy of drug formulations, marking him as a key figure in the field of medicinal chemistry.